At-home COVID-19 treatment Paxlovid was inaccessible to more than 26 million Americans January through March, according to a recent GoodRx analysis. The pharmacy “deserts” spanned 42 percent of the nation’s counties and mainly fell in rural areas.
Read the full post on Becker's Hospital Review - Healthcare News
